Nadia Shobnam, Sarini Saksena, Grace Ratley, Manoj Yadav, Prem Prashant Chaudhary, Ashleigh A Sun, Katherine N Howe, Manasi Gadkari, Luis M Franco, Sundar Ganesan, Katelyn J McCann, Amy P Hsu, Kishore Kanakabandi, Stacy Ricklefs, Justin Lack, Weiming Yu, Morgan Similuk, Magdalena A Walkiewicz, Donna D Gardner, Kelly Barta, Kathryn Tullos, Ian A Myles
BACKGROUND: Topical corticosteroids (TCS) are first-line therapies for numerous skin conditions. Topical Steroid Withdrawal (TSW) is a controversial diagnosis advocated by patients with prolonged TCS exposure who report severe systemic reactions upon treatment cessation. However, to date there have been no systematic clinical or mechanistic studies to distinguish TSW from other eczematous disorders. METHODS: A re-analysis of a previous survey with eczematous skin disease was performed to evaluate potential TSW distinguishing symptoms...
April 19, 2024: medRxiv